Sign in
4

Changes in Ownership

Aptevo Therapeutics Inc. Filed Acc 0001019056-20-000241

Options or other derivatives

  • SVP and CFO acquired 134,800 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Lamothe Jeffrey G. SVP and CFO 2020-02-18 Grant or award · Stock Option (right to buy) +134,800 134,800 D: show line 1 in the form
Loading xslF345X03/lamothe.xml…